Cipla Ltd. — Regulatory Filings 2021

May 31, 2021

1[st] June, 2021

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Response to media query

Dear Sir / Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that in response to media queries on vaccine distribution, Cipla would be releasing the following statement:

"Cipla has been at the forefront of Covid care. We are in the process of seeking clarity & guidance from the Government of India for exploring the possible roadmap for vaccine importation to India. At this stage, no definitive terms have been finalised and hence, the Company cannot comment further.”

Please take the above information on record.

Kindly acknowledge the receipt.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDRA Digitally signed by RAJENDRA CHOPRA CHOPRA Date: 2021.06.01 00:10:52 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Mandar Kurghode